Welcome to TACAD

Caregiving Burden of People Living with Alzheimer’s Disease

Currently, in the U.S., 5.8 million persons are living with Alzheimer’s Disease, subsequently involving about 15 million family caregivers. The wide negative influences of caregiving on health outcomes of family caregivers of persons living with Alzheimer’s Disease (PLAD) have been reported. Furthermore, racial/ethnic minority women including Asian American midlife women are more likely to suffer from caregiving burden compared with their counterparts, mainly due to their cultural attitudes related to Alzheimer’s Disease and caregiving (e.g., stigma, family obligations, women as caregivers).

TACAD has been developed by our team at The University of Texas, Austin.

While considering Asian American midlife women’s cultural attitudes toward Alzheimer’s Disease and caregiving, we developed the first technology-based information and coaching/support program that is tailored for Asian American midlife women who are family caregivers of PLAD (TACAD)

What is TACAD study?

The TACAD study is a federally funded study to preliminarily evaluate TACAD in improving health outcomes of Asian American midlife women who are family caregivers of persons living with Alzheimer’s disease (AACA) and their care recipients. The study is funded by the National Institute of Aging of the National Institute of Health under Award Number 1R21AG075247-01A1. The study will be conducted from 09/01/2022 to 05/31/2025.

For more information, click here.

If you want to participate in TACAD, please click the button below.